Results 171 to 180 of about 1,468,916 (287)
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo+7 more
wiley +1 more source
Twenty-Four-Hour Electrocardiographic Monitoring for Assessment of Cardiac Arrhythmias in Healthy and Hospitalized Goats. [PDF]
Sullivan A+5 more
europepmc +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri+12 more
wiley +1 more source
Incident Arrhythmias Detected Using Implantable Loop Recorders in Obstructive Sleep Apnoea. [PDF]
He H+4 more
europepmc +1 more source
Arrhythmias and Cardiac Output
Patricia Buchholz Kaelin+1 more
openaire +4 more sources
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant+17 more
wiley +1 more source
Closing Editorial for the Special Issue: Cardiac Electrophysiology and Catheter Ablation of Different Arrhythmias. [PDF]
Ali H, Frontera A.
europepmc +1 more source
Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
M. Vaseghi+11 more
semanticscholar +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh+18 more
wiley +1 more source
Genetic Basis of Brugada Syndrome. [PDF]
Xie X, Chen Y, Li Z, Sun Y, Chen G.
europepmc +1 more source